AAAAAA
Results: 1-25/50
Authors:
BRANDAU O
HOLINSKIFEDER E
DERAKHSHANDEHPEYHKAR P
NESTLEKRAMLING C
UNTCH M
KOPP C
GRILL HJ
MURKEN J
MEINDL A
Citation: O. Brandau et al., TOWARDS A MUTATION PROFILE FOR GERMAN BREAST-CANCER FAMILIES, European journal of human genetics, 6, 1998, pp. 1057-1057
Authors:
THOMSSEN C
UNTCH M
KONECNY G
LEBEAU A
DETTMAR P
SATTLER D
KUHN W
KAHLERT S
HEPP H
GRAEFF H
JANICKE F
Citation: C. Thomssen et al., LACK OF CORRELATION BETWEEN C-ERBB-2 OVEREXPRESSION AND THE EFFECT OFDOSE-INTENSIFICATION OF ADJUVANT CHEMOTHERAPY IN HIGH-RISK BREAST-CANCER PATIENTS, European journal of cancer, 34, 1998, pp. 132-132
Authors:
KONECNY G
THOMSSEN C
UNTCH M
KAHLERT S
KUHN W
SATTLER D
PICHE E
LEBEAU A
DETTMAR P
GRAEFF H
JANICKE F
Citation: G. Konecny et al., RANDOMIZED ADJUVANT TRIAL COMPARING 2 DOSE INTENSITIES OF EPIRUBICIN AND CYCLOPHOSPHAMIDE (EC) IN HIGH-RISK BREAST-CANCER, European journal of cancer, 34, 1998, pp. 164-164
Authors:
KAHLERT S
BOETTCHER B
KONECNY G
BAUERFEIND I
NESTLEKRAEMLING C
UNTCH M
Citation: S. Kahlert et al., UROKINASE-LIKE PLASMINOGEN-ACTIVATOR (UPA) AND PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 (PAI-1) IN PRIMARY BREAST-CANCER - PREDICTIVE MARKERSFOR TAMOXIFEN RESISTANCE, European journal of cancer, 34, 1998, pp. 381-381
Authors:
VONMINCKWITZ G
KUHN W
THOMSSEN G
UNTCH M
BAUKNECHT T
EIDTMANN D
MOBUS V
DUBOIS A
LUCK HJ
Citation: G. Vonminckwitz et al., PHASE-III TRIAL COMPARING EPIRUBICIN PACLITAXEL VS EPIRUBICIN/CYCLOPHOSPHAMID AS FIRST LINE TREATMENT IN METASTATIC BREAST-CANCER - PRELIMINARY-RESULTS OF A GERMAN AGO TRIAL/, European journal of cancer, 34, 1998, pp. 406-406
Authors:
SCHROEDER W
LUCK HJ
THOMSSEN C
MOBUS V
KUHN W
VONMINCKWITZ G
UNTCH M
JACKISCH C
KOHLER G
Citation: W. Schroeder et al., PHASE III-MULTICENTER TRIAL EPIRUBICIN-PACLITAXEL VS. EPIRUBICIN-CYCLOPHOSPHAMIDE AS FIRST-LINE THERAPY OF METASTATIC BREAST-CANCER - AN AGO STUDY PROTOCOL, Annals of oncology, 9, 1998, pp. 560-560
Authors:
LUCK HJ
THOMSSEN C
DUBOIS A
UNTCH M
LISBOA B
KOHLER G
DIERGARTEN K
Citation: Hj. Luck et al., METASTATIC BREAST-CANCER - EXPERIENCE WITH THE COMBINATION PACLITAXELPLUS EPIRUBICIN, Oncology, 12(1), 1998, pp. 36-39
Authors:
RITZKE C
STIEBER P
UNTCH M
NAGEL D
EIERMANN W
FATEHMOGHADAM A
Citation: C. Ritzke et al., ALKALINE-PHOSPHATASE ISOENZYMES IN DETECTION AND FOLLOW-UP OF BREAST-CANCER METASTASES, Anticancer research, 18(2B), 1998, pp. 1243-1249
Authors:
SITTEK H
PERLET C
UNTCH M
KESSLER M
REISER MF
Citation: H. Sittek et al., DYNAMIC MR MAMMOGRAPHY IN INVASIVE LOBULAR BREAST-CANCER, Radiology, 209P, 1998, pp. 1469-1469
Authors:
PAHERNIK SA
BOTZLAR A
HILLEMANNS P
DELLIAN M
KIRSCHSTEIN M
ABELS C
KORELL M
MUELLERHOECKER J
UNTCH M
GOETZ AE
Citation: Sa. Pahernik et al., PHARMACOKINETICS AND SELECTIVITY OF AMINOLEVULINIC ACID-INDUCED PORPHYRIN SYNTHESIS IN PATIENTS WITH CERVICAL INTRAEPITHELIAL NEOPLASIA, International journal of cancer, 78(3), 1998, pp. 310-314
Authors:
UNTCH M
FUCHS W
KREIENBERG R
Citation: M. Untch et al., CLINICAL EFFICACY OF LEUPRORELIN ACETATE MONTHLY DEPOT IN PREMENOPAUSAL PATIENTS WITH METASTATIC BREAST-CANCER, Oncology Reports, 4(4), 1997, pp. 717-721
Authors:
WOLLENBERG B
JAN NV
JUND R
CHAUBAL S
UNTCH M
Citation: B. Wollenberg et al., UROKINASE-TYPE PLASMINOGEN-ACTIVATOR AND ITS INHIBITOR PLASMINOGEN-ACTIVATOR INHIBITOR-1 - NEW FUNCTIONAL RISK-FACTORS IN HEAD AND NECK SQUAMOUS-CELL CANCER, Oncology Reports, 4(4), 1997, pp. 853-855
Authors:
ANGIOLI R
JANICEK M
SEVIN BU
ESTAPE R
AVERETTE HE
KOECHLI OR
UNTCH M
PENALVER M
Citation: R. Angioli et al., USE OF LONIDAMINE TO POTENTIATE THE EFFECT OF CISPLATIN AND CARBOPLATIN ON PLATINUM RESISTANT HUMAN OVARIAN-CANCER CELLS, International journal of oncology, 11(4), 1997, pp. 777-780
Authors:
KONECNY G
UNTCH M
HEPP H
Citation: G. Konecny et al., NEW DRUGS IN BREAST-CANCER THERAPY - CURR ENT POSITION AND FUTURE PERSPECTIVES, Gynakologisch-geburtshilfliche Rundschau, 37(2), 1997, pp. 54-61
Authors:
THOMSSEN C
UNTCH M
SCHILL E
SATTLER D
KONECNY G
BAUERNFEIND P
JANICKE F
GRAEFF H
Citation: C. Thomssen et al., DOSE-INTENSIFIED VERSUS STANDARD CHEMOTHERAPY IN HIGH-RISK BREAST-CANCER PATIENTS - PRELIMINARY DATA OF A RANDOMIZED TRIAL, European journal of cancer, 33, 1997, pp. 662-662
Authors:
DRECHSLER S
BRUNTSCH U
EGGERT J
GROTEKIEHN J
GOSSE H
BANGERTER M
UKENA D
OEHM C
MEZGER J
FAERBER L
IMHOFF W
UNTCH M
GALLMEIER WM
Citation: S. Drechsler et al., COMPARISON OF 3 TROPISETRON-CONTAINING ANTIEMETIC REGIMENS IN THE PROPHYLAXIS OF ACUTE AND DELAYED CHEMOTHERAPY-INDUCED EMESIS AND NAUSEA, Supportive care in cancer, 5(5), 1997, pp. 387-395
Authors:
SITTEK H
KESSLER M
HEUCK AF
BREDL T
PERLET C
KUNZER I
LEBEAU A
UNTCH M
REISER M
Citation: H. Sittek et al., THE DUCTAL CARCINOMA IN-SITU IN CONTRAST-ENHANCED DYNAMIC MR MAMMOGRAPHY - MORPHOLOGY AND SIGNAL ENHANCEMENT, RoFo. Fortschritte auf dem Gebiete der Rontgenstrahlen und der neuenbildgebenden Verfahren, 167(3), 1997, pp. 247-251
Authors:
UNTCH M
Citation: M. Untch, GNRH ANALOGS IN METASTATIC BREAST-CANCER, Archives of gynecology and obstetrics, 260(1-4), 1997, pp. 221-222
Authors:
POLLOW K
KREIENBERG R
MAHLKE M
HOFFMANN G
POLLOW B
SCHAFFRATH M
UNTCH M
KLOSS W
GIESEKING F
GOEBE L
HEILMANN L
STRITTMATTER HJ
MELCHERT F
KRETSCHMER M
Citation: K. Pollow et al., HIGH-DOSE MEDROXYPROGESTERONE ACETATE (MP A) THERAPY IN METASTATIC BREAST-CANCER PATIENTS UNDER SPECIAL CONSIDERATION OF MPA SERUM LEVELS -A PROSPECTIVE AND COOPERATIVE STUDY ON THE BASIS OF 178 PATIENTS, Tumordiagnostik & Therapie, 18(2), 1997, pp. 43-50
Authors:
LUCK HJ
THOMSSEN C
DUBOIS A
UNTCH M
LISBOA B
KOHLER G
DIERGARTEN K
Citation: Hj. Luck et al., PHASE-II STUDY OF PACLITAXEL AND EPIRUBICIN AS FIRST-LINE THERAPY IN PATIENTS WITH METASTATIC BREAST-CANCER, Seminars in oncology, 24(5), 1997, pp. 35-39
Authors:
LUCK HJ
THOMSSEN C
DUBOIS A
LISBOA BW
UNTCH M
KUHNLE H
JANICKE F
MEERPOHL HG
LINDNER C
KCNECNY G
HECKER D
DIERGARTEN K
Citation: Hj. Luck et al., PRELIMINARY-RESULTS OF A PHASE-II STUDY OF EPIRUBICIN AND PACLITAXEL AS FIRST-LINE TREATMENT IN PATIENTS WITH METASTATIC BREAST-CANCER, Seminars in oncology, 24(1), 1997, pp. 13-16
Authors:
SITTEK H
PERLET C
HERRMANN K
LINSMEIER E
KOLEM H
UNTCH M
KESSLER M
REISER M
Citation: H. Sittek et al., MR-IMAGING OF THE BREAST - LOCALIZATION OF FOCAL BREAST-LESIONS WITH THE MAGNETOM OPEN AT 0.2 T, Radiologe, 37(9), 1997, pp. 685-691
Authors:
ANGIOLI R
SEVIN BU
UNTCH M
KOCHLI OR
ESTAPE R
AVERETTE HE
Citation: R. Angioli et al., USE OF INTERFERON AND MEDROXYPROGESTERONE ACETATE FOR THE TREATMENT OF ENDOMETRIAL CANCER, Oncology Reports, 3(2), 1996, pp. 351-354
Authors:
CREE IA
KURBACHER CM
UNTCH M
SUTHERLAND LA
HUNTER EM
SUBEDI AMC
JAMES EA
DEWAR JA
PREECE PE
ANDREOTTI PE
BRUCKNER HW
Citation: Ia. Cree et al., CORRELATION OF THE CLINICAL-RESPONSE TO CHEMOTHERAPY IN BREAST-CANCERWITH EX-VIVO CHEMOSENSITIVITY, Anti-cancer drugs, 7(6), 1996, pp. 630-635
Authors:
SITTEK H
KESSLER M
HEUCK AF
LEBEAU A
KOHNERT M
UNTCH M
BOHMERT H
REISER M
Citation: H. Sittek et al., DYNAMIC MR MAMMOGRAPHY - CAN THE COURSE O F SIGNAL INTENSITY INCREASEBE SUITABLE FOR DIFFERENTIATING BETWEEN DIFFERENT FORMS OF MASTOPATHY, RoFo. Fortschritte auf dem Gebiete der Rontgenstrahlen und der neuenbildgebenden Verfahren, 165(1), 1996, pp. 59-63